DE | EN | ES
 
 

News and press releases from HAPILA

Participation in BioEurope 2013 in Vienna

The purification of active pharmaceutical ingredients was an important topic at the BioEurope 2013 in Vienna.

In November this year, Vienna was host to BioEurope - a three-day partnering conference in biotechnology but also with a significant pharmaceutical presence. Key aspects of activity were the "one-to-one" meetings,...[more]

Extension of GMP synthesis capacities

Employees of HAPILA at the new facility

In May 2013, HAPILA commenced operating its second 100L-GMP synthesis plant for the manufacture of pharmaceutical ingredients. By extendingour synthesis capacities, we will be able to react more flexibly to customer expectations...[more]

Displaying results 29 to 30 out of 30
<< First < Previous 1-7 8-14 15-21 22-28 29-30 Next > Last >>